Karunakaran, Denuja http://orcid.org/0000-0002-4789-8634
Turner, Adam W.
Duchez, Anne-Claire
Soubeyrand, Sebastien http://orcid.org/0000-0002-9317-301X
Rasheed, Adil http://orcid.org/0000-0002-3204-6674
Smyth, David
Cook, David P. http://orcid.org/0000-0001-7639-6724
Nikpay, Majid
Kandiah, Joshua W.
Pan, Calvin http://orcid.org/0000-0002-0752-833X
Geoffrion, Michele
Lee, Richard http://orcid.org/0000-0003-1738-1746
Boytard, Ludovic
Wyatt, Hailey
Nguyen, My-Anh
Lau, Paulina
Laakso, Markku http://orcid.org/0000-0002-3394-7749
Ramkhelawon, Bhama http://orcid.org/0000-0002-9087-0995
Alvarez, Marcus
Pietiläinen, Kirsi H. http://orcid.org/0000-0002-8522-1288
Pajukanta, Päivi http://orcid.org/0000-0002-6423-8056
Vanderhyden, Barbara C. http://orcid.org/0000-0002-7644-7189
Liu, Peter
Berger, Scott B.
Gough, Peter J.
Bertin, John
Harper, Mary-Ellen http://orcid.org/0000-0003-3864-5886
Lusis, Aldons J. http://orcid.org/0000-0001-9013-0228
McPherson, Ruth http://orcid.org/0000-0002-9087-6107
Rayner, Katey J. http://orcid.org/0000-0001-6230-426X
Funding for this research was provided by:
National Psoriasis Foundation
Academy of Finland (272376, 266286, 314383)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (HL095056, HL28481 and U01 DK105561, NIH DK117850 HL147883, HL119047)
Gouvernement du Canada | Canadian Institutes of Health Research
Fondation Leducq
Article History
Received: 22 January 2020
Accepted: 10 August 2020
First Online: 28 September 2020
Change Date: 8 October 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: R.L. is an employee of Ionis Pharmaceuticals, S.B.B. is an employee of Janssen Pharmaceuticals, P.J.G. is an employee of Inzen Therapeutics and J.B. is an employee of GlaxoSmithKline. The other authors declare no competing interests.